Global Echinocandins for Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
1 Market Overview
- 1.1 Product Overview and Scope of Echinocandins for Injection
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Echinocandins for Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Caspofungin
- 1.3.3 Micafungin
- 1.3.4 Anidulafungin
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Echinocandins for Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital
- 1.4.3 Drugstore
- 1.5 Global Echinocandins for Injection Market Size & Forecast
- 1.5.1 Global Echinocandins for Injection Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Echinocandins for Injection Sales Quantity (2018-2029)
- 1.5.3 Global Echinocandins for Injection Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Merck
- 2.1.1 Merck Details
- 2.1.2 Merck Major Business
- 2.1.3 Merck Echinocandins for Injection Product and Services
- 2.1.4 Merck Echinocandins for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Merck Recent Developments/Updates
- 2.2 Astellas
- 2.2.1 Astellas Details
- 2.2.2 Astellas Major Business
- 2.2.3 Astellas Echinocandins for Injection Product and Services
- 2.2.4 Astellas Echinocandins for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Astellas Recent Developments/Updates
- 2.3 Endo International
- 2.3.1 Endo International Details
- 2.3.2 Endo International Major Business
- 2.3.3 Endo International Echinocandins for Injection Product and Services
- 2.3.4 Endo International Echinocandins for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Endo International Recent Developments/Updates
- 2.4 Xellia Pharmaceuticals
- 2.4.1 Xellia Pharmaceuticals Details
- 2.4.2 Xellia Pharmaceuticals Major Business
- 2.4.3 Xellia Pharmaceuticals Echinocandins for Injection Product and Services
- 2.4.4 Xellia Pharmaceuticals Echinocandins for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Xellia Pharmaceuticals Recent Developments/Updates
- 2.5 Teva
- 2.5.1 Teva Details
- 2.5.2 Teva Major Business
- 2.5.3 Teva Echinocandins for Injection Product and Services
- 2.5.4 Teva Echinocandins for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Teva Recent Developments/Updates
- 2.6 Hikma
- 2.6.1 Hikma Details
- 2.6.2 Hikma Major Business
- 2.6.3 Hikma Echinocandins for Injection Product and Services
- 2.6.4 Hikma Echinocandins for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Hikma Recent Developments/Updates
- 2.7 Apotex
- 2.7.1 Apotex Details
- 2.7.2 Apotex Major Business
- 2.7.3 Apotex Echinocandins for Injection Product and Services
- 2.7.4 Apotex Echinocandins for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Apotex Recent Developments/Updates
- 2.8 Fresenius
- 2.8.1 Fresenius Details
- 2.8.2 Fresenius Major Business
- 2.8.3 Fresenius Echinocandins for Injection Product and Services
- 2.8.4 Fresenius Echinocandins for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Fresenius Recent Developments/Updates
- 2.9 Pfizer
- 2.9.1 Pfizer Details
- 2.9.2 Pfizer Major Business
- 2.9.3 Pfizer Echinocandins for Injection Product and Services
- 2.9.4 Pfizer Echinocandins for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Pfizer Recent Developments/Updates
- 2.10 CTTQ
- 2.10.1 CTTQ Details
- 2.10.2 CTTQ Major Business
- 2.10.3 CTTQ Echinocandins for Injection Product and Services
- 2.10.4 CTTQ Echinocandins for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 CTTQ Recent Developments/Updates
- 2.11 QILU Pharmaceutical
- 2.11.1 QILU Pharmaceutical Details
- 2.11.2 QILU Pharmaceutical Major Business
- 2.11.3 QILU Pharmaceutical Echinocandins for Injection Product and Services
- 2.11.4 QILU Pharmaceutical Echinocandins for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 QILU Pharmaceutical Recent Developments/Updates
- 2.12 BrightGene Bio-Medical Technology
- 2.12.1 BrightGene Bio-Medical Technology Details
- 2.12.2 BrightGene Bio-Medical Technology Major Business
- 2.12.3 BrightGene Bio-Medical Technology Echinocandins for Injection Product and Services
- 2.12.4 BrightGene Bio-Medical Technology Echinocandins for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 BrightGene Bio-Medical Technology Recent Developments/Updates
- 2.13 Hansoh Pharmaceutical
- 2.13.1 Hansoh Pharmaceutical Details
- 2.13.2 Hansoh Pharmaceutical Major Business
- 2.13.3 Hansoh Pharmaceutical Echinocandins for Injection Product and Services
- 2.13.4 Hansoh Pharmaceutical Echinocandins for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 Hansoh Pharmaceutical Recent Developments/Updates
- 2.14 HISUN
- 2.14.1 HISUN Details
- 2.14.2 HISUN Major Business
- 2.14.3 HISUN Echinocandins for Injection Product and Services
- 2.14.4 HISUN Echinocandins for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.14.5 HISUN Recent Developments/Updates
3 Competitive Environment: Echinocandins for Injection by Manufacturer
- 3.1 Global Echinocandins for Injection Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Echinocandins for Injection Revenue by Manufacturer (2018-2023)
- 3.3 Global Echinocandins for Injection Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Echinocandins for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Echinocandins for Injection Manufacturer Market Share in 2022
- 3.4.2 Top 6 Echinocandins for Injection Manufacturer Market Share in 2022
- 3.5 Echinocandins for Injection Market: Overall Company Footprint Analysis
- 3.5.1 Echinocandins for Injection Market: Region Footprint
- 3.5.2 Echinocandins for Injection Market: Company Product Type Footprint
- 3.5.3 Echinocandins for Injection Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Echinocandins for Injection Market Size by Region
- 4.1.1 Global Echinocandins for Injection Sales Quantity by Region (2018-2029)
- 4.1.2 Global Echinocandins for Injection Consumption Value by Region (2018-2029)
- 4.1.3 Global Echinocandins for Injection Average Price by Region (2018-2029)
- 4.2 North America Echinocandins for Injection Consumption Value (2018-2029)
- 4.3 Europe Echinocandins for Injection Consumption Value (2018-2029)
- 4.4 Asia-Pacific Echinocandins for Injection Consumption Value (2018-2029)
- 4.5 South America Echinocandins for Injection Consumption Value (2018-2029)
- 4.6 Middle East and Africa Echinocandins for Injection Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Echinocandins for Injection Sales Quantity by Type (2018-2029)
- 5.2 Global Echinocandins for Injection Consumption Value by Type (2018-2029)
- 5.3 Global Echinocandins for Injection Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Echinocandins for Injection Sales Quantity by Application (2018-2029)
- 6.2 Global Echinocandins for Injection Consumption Value by Application (2018-2029)
- 6.3 Global Echinocandins for Injection Average Price by Application (2018-2029)
7 North America
- 7.1 North America Echinocandins for Injection Sales Quantity by Type (2018-2029)
- 7.2 North America Echinocandins for Injection Sales Quantity by Application (2018-2029)
- 7.3 North America Echinocandins for Injection Market Size by Country
- 7.3.1 North America Echinocandins for Injection Sales Quantity by Country (2018-2029)
- 7.3.2 North America Echinocandins for Injection Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Echinocandins for Injection Sales Quantity by Type (2018-2029)
- 8.2 Europe Echinocandins for Injection Sales Quantity by Application (2018-2029)
- 8.3 Europe Echinocandins for Injection Market Size by Country
- 8.3.1 Europe Echinocandins for Injection Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Echinocandins for Injection Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Echinocandins for Injection Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Echinocandins for Injection Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Echinocandins for Injection Market Size by Region
- 9.3.1 Asia-Pacific Echinocandins for Injection Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Echinocandins for Injection Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Echinocandins for Injection Sales Quantity by Type (2018-2029)
- 10.2 South America Echinocandins for Injection Sales Quantity by Application (2018-2029)
- 10.3 South America Echinocandins for Injection Market Size by Country
- 10.3.1 South America Echinocandins for Injection Sales Quantity by Country (2018-2029)
- 10.3.2 South America Echinocandins for Injection Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Echinocandins for Injection Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Echinocandins for Injection Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Echinocandins for Injection Market Size by Country
- 11.3.1 Middle East & Africa Echinocandins for Injection Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Echinocandins for Injection Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Echinocandins for Injection Market Drivers
- 12.2 Echinocandins for Injection Market Restraints
- 12.3 Echinocandins for Injection Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Echinocandins for Injection and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Echinocandins for Injection
- 13.3 Echinocandins for Injection Production Process
- 13.4 Echinocandins for Injection Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Echinocandins for Injection Typical Distributors
- 14.3 Echinocandins for Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Echinocandins for Injection market size was valued at USD 916.8 million in 2022 and is forecast to a readjusted size of USD 1184.9 million by 2029 with a CAGR of 3.7% during review period.
Echinocandins are a class of antifungal drugs that inhibit the synthesis of β-glucan in the fungal cell wall via noncompetitive inhibition of the enzyme 1,3-β glucan synthase. The class has been termed the "penicillin of antifungals," along with the related papulacandins, as their mechanism of action resembles that of penicillin in bacteria.
Echinocandins are a class of antifungal medications administered through injection, widely used to treat severe fungal infections. These drugs target the β-1,3-glucan synthase enzyme in the fungal cell wall, leading to the inhibition of cell wall synthesis and subsequent fungal cell death. Common echinocandins include caspofungin, anidulafungin, and micafungin, often utilized in the treatment of refractory candidiasis such as invasive candidiasis. They typically require strict medical supervision and judicious use due to their lower toxicity targeting fungal cell wall synthesis, making them an important choice in combating fungal infections.
The Global Info Research report includes an overview of the development of the Echinocandins for Injection industry chain, the market status of Hospital (Caspofungin, Micafungin), Drugstore (Caspofungin, Micafungin), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Echinocandins for Injection.
Regionally, the report analyzes the Echinocandins for Injection markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Echinocandins for Injection market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Echinocandins for Injection market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Echinocandins for Injection industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Caspofungin, Micafungin).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Echinocandins for Injection market.
Regional Analysis: The report involves examining the Echinocandins for Injection market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Echinocandins for Injection market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Echinocandins for Injection:
Company Analysis: Report covers individual Echinocandins for Injection manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Echinocandins for Injection This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Drugstore).
Technology Analysis: Report covers specific technologies relevant to Echinocandins for Injection. It assesses the current state, advancements, and potential future developments in Echinocandins for Injection areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Echinocandins for Injection market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Echinocandins for Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Caspofungin
Micafungin
Anidulafungin
Market segment by Application
Hospital
Drugstore
Major players covered
Merck
Astellas
Endo International
Xellia Pharmaceuticals
Teva
Hikma
Apotex
Fresenius
Pfizer
CTTQ
QILU Pharmaceutical
BrightGene Bio-Medical Technology
Hansoh Pharmaceutical
HISUN
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Echinocandins for Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Echinocandins for Injection, with price, sales, revenue and global market share of Echinocandins for Injection from 2018 to 2023.
Chapter 3, the Echinocandins for Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Echinocandins for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Echinocandins for Injection market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Echinocandins for Injection.
Chapter 14 and 15, to describe Echinocandins for Injection sales channel, distributors, customers, research findings and conclusion.